|
1
|
Daskivich TJ, Fan KH, Koyama T, Albertsen
PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM and
Litwin MS: Original research effect of age, tumor risk and
comorbidity on competing risks. Ann Intern Med. 158:709–717. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Honorable T and Lew JJ: Social security.
Available via DIALOG. https://www.ssa.gov/OACT/population/longevity.htmlMarch
1–2018
|
|
4
|
Smith RA, Manassaram-Baptiste D, Brooks D,
Doroshenk M, Fedewa S, Saslow D, Brawley OW and Wender R: Cancer
screening in the United States, 2015: A review of current American
cancer society guidelines and current issues in cancer screening.
CA Cancer J Clin. 65:30–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Heidenreich A, Bastian PJ, Bellmunt J,
Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T,
Zattoni F, et al: EAU guidelines on prostate cancer. part 1:
Screening, diagnosis, and local treatment with curative
intent-update 2013. Eur Urol. 65:124–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin K, Lipsitz R, Miller T and Janakiraman
S; U.S. Preventive Services Task Force, : Benefits and harms of
prostate-specific antigen screening for prostate cancer: An
evidence update for the U.S. Preventive Services Task Force. Ann
Intern Med. 149:192–199. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carter HB, Albertsen PC, Barry MJ, Etzioni
R, Freedland SJ, Greene KL, Holmberg L, Kantoff P, Konety BR, Murad
MH, et al: Early detection of prostate cancer: AUA guideline. J
Urol. 190:419–426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Williamson DA, Barrett LK, Rogers BA,
Freeman JT, Hadway P and Paterson DL: Infectious complications
following transrectal ultrasound-guided prostate biopsy: New
challenges in the era of multidrug-resistant Escherichia coli. Clin
Infect Dis. 57:267–274. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schröder F and Kattan MW: The
comparability of models for predicting the risk of a positive
prostate biopsy with prostate-specific antigen alone: A systematic
review. Eur Urol. 54:274–290. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sonn GA, Chang E, Natarajan S, Margolis
DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE and Marks LS:
Value of targeted prostate biopsy using magnetic
resonance-ultrasound fusion in men with prior negative biopsy and
elevated prostate-specific antigen. Eur Urol. 65:809–815. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pokorny MR, de Rooij M, Duncan E, Schröder
FH, Parkinson R, Barentsz JO and Thompson LC: Prospective study of
diagnostic accuracy comparing prostate cancer detection by
transrectal ultrasound-guided biopsy versus magnetic resonance (MR)
imaging with subsequent MR-guided biopsy in men without previous
prostate biopsies. Eur Urol. 66:22–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hoeks CM, Schouten MG, Bomers JG,
Hoogendoorn SP, Hulsbergen-van de Kaa CA, Hambrock T, Vergunst H,
Sedelaar JP, Fütterer JJ and Barentsz JO: Three-Tesla magnetic
resonance-guided prostate biopsy in men with increased
prostate-specific antigen and repeated, negative, random,
systematic, transrectal ultrasound biopsies: Detection of
clinically significant prostate cancers. Eur Urol. 62:902–909.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hattori S, Kosaka T, Mizuno R, Kanao K,
Miyajima A, Yasumizu Y, Yazawa S, Nagata H, Kikuchi E, Mikami S, et
al: Prognostic value of preoperative multiparametric magnetic
resonance imaging (MRI) for predicting biochemical recurrence after
radical prostatectomy. BJU Int. 113:741–747. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Barentsz JO, Richenberg J, Clements R,
Choyke P, Verma S, Villeirs G, Rouviere O, Logager V and Fütterer
JJ; European Society of Urogenital Radiology, : ESUR prostate MR
guidelines 2012. Eur Radiol. 22:746–757. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kikuchi E, Nakashima J, Ishibashi M,
Ohigashi T, Asakura H, Tachibana M and Murai M: Prostate specific
antigen adjusted for transition zone volume: The most powerful
method for detecting prostate carcinoma. Cancer. 89:842–849. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Distler FA, Radtke JP, Bonekamp D, Kesch
C, Schlemmer HP, Wieczorek K, Kirchner M, Pahernik S, Hohenfellner
M and Hadaschik BA: The value of PSA density in combination with
PI-RADSTM for the accuracy of prostate cancer
prediction. J Urol. 198:575–582. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kubota Y, Kamei S, Nakano M, Ehara H,
Deguchi T and Tanaka O: The potential role of prebiopsy magnetic
resonance imaging combined with prostate-specific antigen density
in the detection of prostate cancer. Int J Urol. 15:322–327. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kosaka T, Mizuno R, Shinojima T, Miyajima
A, Kikuchi E, Tanaka N, Shinoda K, Morita S, Mikami S and Oya M:
The implications of prostate-specific antigen density to predict
clinically significant prostate cancer in men ≤50 years. Am J Clin
Exp Urol. 2:332–336. 2014.PubMed/NCBI
|
|
19
|
Daskivich TJ, Fan KH, Koyama T, Albertsen
PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM,
Litwin MS and Penson DF: Effect of age, tumor risk, and comorbidity
on competing risks for survival in a U.S. population-based cohort
of men with prostate cancer. Ann Intern Med. 158:709–717. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van den Bergh RC, Roemeling S, Roobol MJ,
Aus G, Hugosson J, Rannikko AS, Tammela TL, Bangma CH and Schröder
FH: Outcomes of men with screen-detected prostate cancer eligible
for active surveillance who were managed expectantly. Eur Urol.
55:1–8. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tosoian JJ, Trock BJ, Landis P, Feng Z,
Epstein JI, Partin AW, Walsh PC and Carter HB: Active surveillance
program for prostate cancer: An update of the Johns Hopkins
experience. J Clin Oncol. 29:2185–2190. 2011. View Article : Google Scholar : PubMed/NCBI
|
